Hemolytic anemia
Hemolytic anemia ( 15 Questions)
"To stimulate the production of fetal hemoglobin" is not the purpose of corticosteroids in the treatment and management of hemolytic anemia. Corticosteroids are primarily used to suppress the immune response and reduce the destruction of red blood cells by autoantibodies. Fetal hemoglobin is typically produced during fetal development and is not a target of corticosteroid therapy.
The correct purpose of corticosteroids in hemolytic anemia is "To block the binding of autoantibodies to RBCs." Corticosteroids, such as prednisone, are often prescribed to reduce the autoimmune response that leads to the destruction of red blood cells. By inhibiting the binding of autoantibodies to red blood cells, corticosteroids help to decrease hemolysis and improve anemia.
"To surgically remove the spleen" is a treatment option in some cases of hemolytic anemia, particularly when the spleen is enlarged and contributing to the destruction of red blood cells. However, it is not the primary purpose of corticosteroid therapy.
"To improve tissue oxygenation" is not the primary purpose of corticosteroids in the treatment and management of hemolytic anemia. While corticosteroids may indirectly improve tissue oxygenation by reducing hemolysis, their primary role is to modulate the autoimmune response and reduce the destruction of red blood cells.
Choice A rationale:
"To stimulate the production of fetal hemoglobin" is not the purpose of corticosteroids in the treatment and management of hemolytic anemia.
Corticosteroids are primarily used to suppress the immune response and reduce the destruction of red blood cells by autoantibodies.
Fetal hemoglobin is typically produced during fetal development and is not a target of corticosteroid therapy.
Choice B rationale:
The correct purpose of corticosteroids in hemolytic anemia is "To block the binding of autoantibodies to RBCs." Corticosteroids, such as prednisone, are often prescribed to reduce the autoimmune response that leads to the destruction of red blood cells.
By inhibiting the binding of autoantibodies to red blood cells, corticosteroids help to decrease hemolysis and improve anemia.
Choice C rationale:
"To surgically remove the spleen" is a treatment option in some cases of hemolytic anemia, particularly when the spleen is enlarged and contributing to the destruction of red blood cells.
However, it is not the primary purpose of corticosteroid therapy.
Choice D rationale:
"To improve tissue oxygenation" is not the primary purpose of corticosteroids in the treatment and management of hemolytic anemia.
While corticosteroids may indirectly improve tissue oxygenation by reducing hemolysis, their primary role is to modulate the autoimmune response and reduce the destruction of red blood cells.